Replies to post #153533 on Avid Bioservices Inc (CDMO)

[revenue_monster]

Chimeric antibody has long history of failure? How about erbitux and rituxan? If $7B in sales is failure then I hope BAVI fails

The drug: Rituxan
Company: Roche
Estimated worldwide sales 2012: $6.94 billion

Read more: Rituxan - FiercePharma http://www.fiercepharma.com/special-reports/rituxan#ixzz2orxtDVOe
Subscribe at FiercePharma